Comparison of the effect of oral and intravenous iron supplementation on quality of life and function of patients with heart failure
Phase 3
Recruiting
- Conditions
- Anaemia in chronic diseases classified elsewhere.Anaemia in chronic diseases classified elsewhereD63.8
- Registration Number
- IRCT20180205038626N15
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 180
Inclusion Criteria
Patients with heart failure
Age above 18 years
Serum ferritin levels <100 or TS <20%
Ferritin 100-300 and hemoglobin below 15
Exclusion Criteria
Known and treated anemia
Allergy or intolerance to iron supplements
Duodenal or gastric ulcer, gastrointestinal disease with impaired iron absorption
Oncological diseases
History of surgery 6 months before entering the study
Active bleeding and the need for blood transfusion in patients with shock or sepsis
Unwillingness to continue the study or cause any dissatisfaction in the field of taking iron supplements or participating in the study
Acute heart failure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method